Clinical research to evaluation the safety and efficacy of volume-reduced washed platelets in children with cancer.

Clinical research to evaluation the safety and efficacy of volume-reduced washed platelets in children with cancer. - Clinical research to evaluation the safety and efficacy of volume-reduced washed platelets in children with cancer.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031481

Enrollment

Registered

2018-02-26

Start date

2017-06-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

children with cancer.

Interventions

Replaced platelet concentrates were transfused four times. Replaced platelet concentrates were suspended with conventional volume of solution (two times) and half volume of solution (two times). Conv

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diagnosed as a hematologic malignancy and requires multiple platelet transfusions.

Exclusion criteria

Exclusion criteria: Platelet transfusion refractory state

Design outcomes

Primary

Measure	Time frame
corrected count increment after 24hrs	—

Countries

Japan

Contacts

Public ContactRyu Yanagisawa

Shinshu University Hospital Blood Transfusion

ryu@shinshu-u.ac.jp0263-37-3240

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026